Literature DB >> 2863149

Tissue distribution of exaprolol in rat.

V Faberová, T Trnovec, M Zemánek, S Bezek, M Durisová, O Tomcíková.   

Abstract

The disposition of the beta adrenoceptor blocking drug 1-(2-cyclohexylphenoxy)-3-isopropylamino-2-propanol, exaprolol, in organs of the rat has been studied. After i.v. administration of 3H-exaprolol a transient extremely high accumulation of the drug in lungs was observed with a peak of 7.7% of dose/g 30 min post-administration. The disposition pattern in heart, kidneys and liver may be characterized by a tissue to plasma ratio about ten. Lower exaprolol tissue levels were observed after oral administration. The tissue to plasma ratios showed an initial increase followed by constant levels. The distribution of exaprolol in organs of the rat is discussed in the light of the previously determined pharmacokinetic parameters.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863149     DOI: 10.1007/BF03189691

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Lung accumulation of some beta-adrenoceptor antagonists [proceedings].

Authors:  J A Street; I Gonda; H Parkinson; B A Hemsworth
Journal:  J Pharm Pharmacol       Date:  1978-12       Impact factor: 3.765

2.  Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol.

Authors:  M Carissimi; P Gentili; E Grumelli; E Milla; G Picciola; F Ravenna
Journal:  Arzneimittelforschung       Date:  1976-04

3.  Absorption, distribution and excretion of alprenolol in man, dog and rat.

Authors:  N O Bodin; K O Borg; R Johansson; H Obianwu; R Svensson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-10

4.  In vitro accumulation of (+/-)-oxprenolol by rat lung [proceedings].

Authors:  B A Hemsworth; J A Street
Journal:  Br J Pharmacol       Date:  1979-07       Impact factor: 8.739

5.  Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.

Authors:  A Hayes; R G Cooper
Journal:  J Pharmacol Exp Ther       Date:  1971-02       Impact factor: 4.030

6.  Disposition of exaprolol, a new beta-blocker, in rats.

Authors:  T Trnovec; M Zemánek; V Faberová; S Bezek; M Durisová; E Ujházy; O Tomcíková
Journal:  Drug Metab Dispos       Date:  1982 Sep-Oct       Impact factor: 3.922

7.  Aspects of the cardiovascular pharmacology of exaprolol.

Authors:  B Hughes; K A Kane; F M McDonald; J R Parratt
Journal:  J Pharm Pharmacol       Date:  1984-09       Impact factor: 3.765

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.